7-Hydroxystaurosporine

N/A

Report date: 2022/08/29 20:00:24
NME

Base Information

Drug Name7-Hydroxystaurosporine
Drug Alias NameUCN-01UCN-02KW-2401KRX-0601NSC-638850
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C inhibitors3-phosphoinositide-dependent protein kinase 1 inhibitorsCheckpoint kinase 2 inhibitors +[4] 
Targets3-phosphoinositide-dependent protein kinase 1Checkpoint kinase 2Protein kinase C +[4] 
Therapy Area/IndicationsSolid tumoursMyelodysplastic SyndromesMyelodysplastic-Myeloproliferative Diseases +[65] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKyowa Hakko Kirin Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of California San FranciscoKeryx Biopharmaceuticals IncNational Cancer Institute +[5] 
Active IndicationsN/A
Inactive IndicationsSolid tumoursMyelodysplastic SyndromesMyelodysplastic-Myeloproliferative Diseases +[65] 

Other Information

ATC CodeN/A
Related LinksN/A